Control Bionics Limited provided revenue guidance for the year ended 30 June 2023. The revenue for the year ended 30 June 2023 is expected to be approximately $5.3 million, a more than 20% increase in the revenue of $4.4 million for the year ended 30 June 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.057 AUD | +32.56% |
|
+26.67% | +23.91% |
01:28am | Control Bionics' DROVE Autonomous Wheelchair Module Secures Australia Approval | MT |
05-17 | Control Bionics Raises AU$130,000 via Additional Commitments for Placement | MT |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+23.91% | 5.72M | |
-51.68% | 2.38B | |
+25.12% | 1.98B | |
-8.77% | 1.52B | |
+22.81% | 1.26B | |
-21.62% | 902M | |
-1.69% | 752M | |
-32.86% | 767M | |
-25.90% | 621M | |
+23.58% | 580M |
- Stock Market
- Equities
- CBL Stock
- News Control Bionics Limited
- Control Bionics Limited Provides Revenue Guidance for the Year Ended 30 June 2023